A MAGE-A3 peptide presented by HLA-DP4 is recognized on tumor cells by CD4+ cytolytic T lymphocytes.

被引：0
|
作者：
Schultz, ES
Schuler-Thurner, B
Lethé, B
Cambiaso, CL
Van Snick, J
Chaux, P
Corthals, J
Heirman, C
Thielemans, K
Boon, T
van der Bruggen, P
机构：
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2000年 / 115卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
O3
引用
收藏
页码：1170 / 1170
页数：1
相关论文
共 50 条
  • [1] A MAGE-A3 peptide presented by HLA-DP4 is recognized on tumor cells by CD4+ cytolytic T lymphocytes
    Schultz, ES
    Lethé, B
    Cambiaso, CL
    Van Snick, J
    Chaux, P
    Corthals, J
    Heirman, C
    Thielemans, K
    Boon, T
    van der Bruggen, P
    [J]. CANCER RESEARCH, 2000, 60 (22) : 6272 - 6275
  • [2] A MAGE-A3 peptide presented by HLA-DP4 tumor cells to CD4+ cytolytic T lymphocytes
    Schultz, ES
    Lethé, B
    Van Snick, J
    Chaux, P
    Thielemans, K
    Corthals, J
    Heirman, C
    Boon, T
    van der Bruggen, P
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (03) : 563 - 563
  • [3] A MAGE-A4 peptide presented by HLA-A2 is recognized by cytolytic T lymphocytes
    Duffour, MT
    Chaux, P
    Lurquin, C
    Cornelis, G
    Boon, T
    van der Bruggen, P
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1999, 29 (10) : 3329 - 3337
  • [4] New MAGE-4 antigenic peptide recognized by cytolytic T lymphocytes on HLA-A1 tumor cells
    Kobayashi, T
    Lonchay, C
    Colau, D
    Demotte, N
    Boon, T
    van der Bruggen, P
    [J]. TISSUE ANTIGENS, 2003, 62 (05): : 426 - 432
  • [5] A MAGE-A4 peptide presented by HLA-B37 is recognized on human tumors by cytolytic T lymphocytes
    Zhang, Y
    Stroobant, V
    Russo, V
    Boon, T
    van der Bruggen, P
    [J]. TISSUE ANTIGENS, 2002, 60 (05): : 365 - 371
  • [6] A new MAGE-4 antigenic peptide recognized by cytolytic T lymphocytes on HLA–A24 carcinoma cells
    Sabrina Ottaviani
    Didier Colau
    Pierre van der Bruggen
    Pierre van der Bruggen
    [J]. Cancer Immunology, Immunotherapy, 2006, 55 : 867 - 872
  • [7] A new MAGE-4 antigenic peptide recognized by cytolytic T lymphocytes on HLA-A24 carcinoma cells
    Ottaviani, S
    Colau, D
    van der Bruggen, P
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2006, 55 (07) : 867 - 872
  • [8] Endosomal proteases influence the repertoire of MAGE-A3 epitopes recognized in vivo by CD4+ T cells
    Marturano, Jill
    Longhi, Renato
    Russo, Vincenzo
    Protti, Maria Pia
    [J]. CANCER RESEARCH, 2008, 68 (05) : 1555 - 1562
  • [9] A MAGE-1 peptide recognized on HLA-DR15 by CD4+ T cells
    Chaux, P
    Lethé, B
    Van Snick, J
    Corthals, J
    Schultz, ES
    Cambiaso, CL
    Boon, T
    van der Bruggen, P
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2001, 31 (06) : 1910 - 1916
  • [10] Prediction of CD4+ T cell epitopes restricted to HLA-DP4 molecules
    Busson, Marc
    Castelli, Florence A.
    Wang, Xiao-Fei
    Cohen, William M.
    Charron, Dominique
    Menez, Andre
    Maillere, B.
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 2006, 317 (1-2) : 144 - 151
12345